Hetero launches generic Lapatinib under the brand name HERTAB in India Farhat Nasim12 Jan 2019 6:44 AM GMTHERTAB (Lapatinib) is an oral therapy indicated for the treatment of postmenopausal women with HER2-positive advanced breast cancer patients whose...